De Gracia, Rixnel B.

HRN: 22-07-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2022
10/17/2022
IVTT
250mg
Q8
Amoebiasis
Waiting Final Action 
10/17/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/17/2022
10/24/2022
ORAL
12 Ml
8 Hrs
Intestinal Amebiasis
Waiting Final Action 
10/17/2022
CEFUROXIME 750MG (VIAL)
10/17/2022
10/24/2022
IVTT
600mg
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: